Adaobi Kanu
Pediatric Pulmonology · Lubbock, TXNPI 1518905934
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,891 of the $4,492 with a category attached, or 86.6%. It is spread thinly across 27 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations.
Across 160 payments — averaging $28.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$865
- Vertex$568
- Amgen$476
- Chiesi USA, Inc.$436
- Sanofi$360
- Mylan Specialty L.p.$210
- plus $2K from 21 others
What the payments were for
- Food & beverage$3,89187%
- Education$52512%
- Gifts$762%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 20 | $865 |
| Vertex | 22 | $568 |
| Amgen | 17 | $476 |
| Chiesi USA, Inc. | 24 | $436 |
| Sanofi | 10 | $360 |
| Mylan Specialty L.p. | 9 | $210 |
| Genentech USA, Inc. | 9 | $197 |
| Gilead | 5 | $182 |
| AbbVie(2 entities) | 9 | $172 |
| Insmed, Inc. | 4 | $150 |
| GSK | 8 | $145 |
| Regeneron Healthcare Solutions, Inc. | 2 | $136 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $117 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Philips North America LLC | 6 | $94 |
| Advanced Respiratory, Inc | 2 | $51 |
| Alcresta Therapeutics, Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Viatris Specialty LLC | 1 | $25 |
| Electromed, Inc. | 1 | $24 |
| Tandem Diabetes Care, Inc. | 1 | $22 |
| Sanofi US Services Inc. | 1 | $21 |
| Vivus LLC | 1 | $21 |
| Baxter Healthcare | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Merck | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,492 in reported general payments places this provider in the 75th percentile of 104 pediatric pulmonology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrikaftaElexacaftor/Tezacaftor/Ivacaft | 16 | $423,515 |
| Lactulose | 17 | $662 |
| Alprazolam | 12 | $610 |
| Oxycodone Hcl | 14 | $451 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $373 |
| Levocetirizine Dihydrochloride | 12 | $221 |
| Azithromycin | 15 | $211 |
| Tizanidine Hcl | 14 | $206 |
| Montelukast Sodium | 12 | $30 |
| Trazodone Hcl | 12 | $17 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| VertexTrikafta | $568 | $423,51516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 104 pediatric pulmonology providers in Texas.
Other pediatric pulmonology in Lubbock
- Sarat SusarlaHouston$194K
- Jason FullmerAustin$74K
- Kelly SmithSan Antonio$69K
- Carolyn CannonDallas$55K
- Shailendra DasFort Worth$23K
- Donna Willey-CourandSan Antonio$19K
- Fadel RuizHouston$17K
- Peter HiattHouston$16K
- Steven CopenhaverDallas$13K
- Tarak PatelSan Antonio$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.